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Serotonin 1A receptor-mediated signaling through
ERK and PKCa is essential for normal synaptogenesis
in neonatal mouse hippocampus
A Mogha1, SR Guariglia2, PR Debata2, GY Wen2,3 and P Banerjee1,2,3,4
Aberrant expression of the presynaptic serotonin 1A receptor (5-HT1A-R) because of a polymorphism in the 5-HT1A-R gene is
associated with severe depression in human, whereas its absence up to postnatal day 21 (P21) in the forebrain of mice results
in heightened anxiety in adulthood. These observations collectively indicate that the 5-HT1A-R has a crucial role in brain
development. To understand the mechanistic underpinnings of this phenomenon, we used organotypic slice cultures of
hippocampi from C57BL6 mice (C57) at P15, which coincides with the peak of neonatal synaptogenesis. Stimulation of the
hippocampal 5-HT1A-R caused a dramatic increase in PSD95 expression and dendritic spine and synapse formation through
sequential activation of the mitogen-activated protein kinase isozymes Erk1/2 and protein kinase C (PKC). Intrahippocampal
infusion of 5-HT1A-R agonists and signaling inhibitors at P15 revealed that the same pathway through PKCa augments PSD95
expression and synaptogenesis in vivo in 24 h in both C57 as well as Swiss Webster mice. Furthermore, intrahippocampal
infusion of the antidepressant fluoxetine, a serotonin reuptake inhibitor, also augmented PSD95 expression and synaptogenesis
through the same pathway. This increased synaptogenesis was observed even 5 days after treatment. Finally, compared with the
wild type, the 5-HT1A-R(/) mice harbor significantly less synapses in the hippocampus, but infusion of the PKC-stimulator and
Alzheimer drug bryostatin into the 5-HT1A-R(/) mice to bypass the non-existent 5-HT1A-R boosted PSD95 expression and
synaptogenesis. The elucidated signaling cascade explains how 5-HT1A-R regulates hippocampal sculpting and function, which
may determine the affective phenotype of an adult.
Translational Psychiatry (2012) 2, e66; doi:10.1038/tp.2011.58; published online 10 January 2012
Introduction
Signaling activity mediated by the brain serotonin 1A receptor
(5–HT1A-R) has been implicated in a large number of
behavioral abnormalities. Both decreased as well as in-
creased 5–HT1A-R signaling in the brain have been linked to a
number of affective disorders. In post-mortem human studies,
increased 5–HT1A-R agonist binding has been observed in the
frontal cortex of schizophrenia patients.1 Positron emission
tomography have indicated above-normal levels of serotonin
in the brain of adolescent autistic children,2 which may elicit
elevated 5–HT1A-R signaling. Similarly, in mouse studies, an
increase in brain serotonin because of monoamine oxidase
A-deficiency during the critical period of development resulted
in the lack of barrels in the somatosensory cortex.3 Con-
versely, other studies showed that a systemic absence of
the 5-HT1A receptor was associated with elevated levels
of anxiety.4–6 More recent experiments have shown that
elimination of the presynaptic 5-HT1A auto receptors but not
the heteroreceptors from P14 is sufficient for the development
of anxiety phenotype in adulthood.7 The same report submits
that elimination of the 5-HT1A heteroreceptors (but not the
autoreceptors) starting from early brain development
elicits increased behavioral despair, which is believed to be
the mouse equivalent of depression. Further emphasizing
the importance of brain 5-HT1A-R levels, an earlier report
showed that a C-1019G polymorphism in the promoter of the
5-HT1A receptor gene causes de-repressed expression of
the 5-HT1A autoreceptor selectively in the serotonergic raphe´
neurons and suggest a downregulation of the same receptor
in the postsynaptic neurons.8 This is associated with severe
depression and suicide.9 Similarly, attenuated 5-HT1A-R
expression has been reported in the cortex of suicide
victims.10 Finally, post-mortem analysis of human brain sam-
ples revealed that reduced 5-HT1A-R binding in the temporal
cortex correlates with aggressive behavior in Alzheimer
patients.11
Thus, prior studies strongly indicate that an optimal level of
5-HT1A-R signaling is required during brain development
for normal affect in adulthood. However, the biochemical
cascades, which are initiated by serotonin binding to the
5-HT1A-R and the identity of downstream signaling proteins
that help in the formation of brain structures and circuitry
during neonatal brain development have remained unclear.
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This study focuses on the hippocampus, which harbors high
levels of the 5-HT1A heteroreceptors, to address four funda-
mental issues: (i) If increased 5-HT1A-R signaling affects
neonatal synaptogenesis; (ii) What signaling pathway is
involved in this process? (iii) Does the absence of this cascade
in the 5-HT1A-R(/) mice affect synaptogenesis? (iv) Could
we normalize synaptogenesis by stimulating a downstream
member of this pathway in the 5-HT1A-R(/) mice?
Our earlier studies in mouse brain slices demonstrated a
5-HT1A-R-evoked increase in field excitatory postsynaptic
potential (fEPSP) in the Schaffer Collateral pathway of the
hippocampus at P15.12 This report also showed that a
5-HT1A-R-linked mitogen-activated protein kinase pathway,
linked to protein kinase C (PKC), was involved in the boosted
synaptic activity. The current study addresses the possibility
that this pathway is operant in vivo in the P15 hippocampus
and it regulates synaptogenesis, which is known to be at its
peak in the cortex at P15.13
Results presented here establish the importance of a
synaptogenic pathway involving 5-HT1A-R, Erk and PKCa in
the neonatal hippocampus. Hyper-normal levels of cortical
serotonin is believed to occur in autism 2 and also with the use
of selective serotonin reuptake inhibitors during adolescence.
On the basis of our results, such a hyperserotonemic state
could elicit aberrant hippocampal development via unwanted
synaptogenesis through the same signaling pathway, thereby
causing local overconnectivity, which is believed to occur in
autism.14
Materials and methods
Reagents. See Supplementary Methods.
Animals. C57BL6 5-HT1A-R(þ /) mice were obtained as
a kind gift from Dr Laurence Tecott 4 and then bred to obtain
5-HT1A-R(/) mice. Genotyping was performed by PCR
using the following primers: Wild type: Fwd 50-ctgctcatgc
tggtcctctatg-30, Rvs 50-taggaggtagctcctgattcgc-30 (product:
323 bp); KO: Fwd 50-caccttgctcctgccgagaaa-30, Rvs 50-agaag
gcgatagaaggcgatg-30 (product: 464 bp). Swiss Webster
(SW) 5-HT1A-R(/) mice were obtained from Dr Toni
Shippenberg.15 Mice were housed in the College of Staten
Island Animal Care Facility and handled following a protocol
approved by the CSI Institutional Animal Care Committee.
Hippocampal slice culture. Details of the procedure for
hippocampal slice culture have been reported earlier and
also included in the Supplementary Methods.12
Western blotting. Details of the western-blotting procedure
have been included in the Supplementary Methods.
Intra-hippocampal injections. (See Supplementary Methods
for details). Injections were made at stereotaxic coordinates
corresponding to Bregma: anterioposterior¼1.8 mm, medio-
lateral¼1.5 mm, dorsoventral¼1.8 mm. This corresponds
to a site in the dorsal hippocampus in the apical dendritic zones
of the CA1 region near the hippocampal fissure.16 A 10-ml
Hamilton syringe was used to deliver the drugs into the
hippocampi of the pups17 at the rate of 1ml per minute using a
stereotaxic set-up (KDS Model 310 plus infusion-withdrawal
syringe pump).
Drug concentrations and infusion strategy. (See
Supplementary Methods for details). Drug concentrations
were made for the observed hippocampal volume of 10 ml
at P15. Inhibitors were infused 30 min before infusing
8-OH-DPAT or fluoxetine.
Immunohistochemistry. (See Supplementary Methods
for details). Hippocampal sections were blocked in (0.1%
Triton X-100, 10% serum from the animal used to raise the
secondary antibody-in 1PBS) for overnight at 4 1C. This
was followed by treatment with primary antibody in antibody
solution (0.1% Triton X-100, 2% serum-in 1 PBS) for
48 h at 4 1C and then with fluorescent secondary antibody
covalently linked to Alexa Fluor 488 (Green) or Alexa Fluor
568 (Red) for 24 h.
Confocal microscopy of the immunostained slices,
fluorescence quantification, counting of spine numbers
and statistical analysis. (See Supplementary Methods for
details). All the images were acquired with the frame average
of four using a Nikon C1-LU3 laser-scanning confocal system
(Nikon Instruments Inc., 1300 Walt Whitman Road, Melville,
NY, USA). The Nikon EZ-C1-system software was used to
determine the total thickness of each slice after adjusting
channels to obtain pictures from each exciting wavelength
separately. In addition to images taken at  4 and  20,
Z-stacks were also acquired at  40 and such volume-
rendered representative images were used in the figures
shown in this report. All the values were then converted to
percent ‘Carrier-treated’. Statistical analysis was carried out
using ANOVA with Bonferroni post hoc test.
Electron microscopic studies. Animals were anesthetized
with the ketamineþ xylazine mixture according to the sugges-
ted dosage and were perfused intra-cardially with 2.5%
glutaraldehydeþ 4% paraformaldehyde for 15 min. Brains
were removed and were post fixed in the same perfusion
solution overnight. Hippocampi were removed and 1-mm
thick sections were cut. After washing with 0.1 M PBS for
30 min (3 ) brain sections were post-fixed in 1% osmium
tetra-oxide for 90 min.18 Sections were rinsed again with 0.1 M
PBS for 30 min and dehydrated with graded ethanol (50%,
70%, 85%, 95%, 2 100%) for 10 min each step, infiltrated
with propylene oxide and plastic Spurr medium, and finally
embedded with pure Spurr medium19 in BEEM capsules and
polymerized in oven at 70 1C overnight. Ultrathin sections
(70–100 nm) were placed on uncoated 200 mesh copper
grids, stained with saturated uranyl acetate in 50% ethanol for
2 min, rinsed with 0.22mM Millipore-filtered distilled water for
2 min to obtain clean sections without any trace of uranyl
acetate residue, stained with Reynolds’s lead citrate for 90 s,
and rinsed with Millipore-filtered distilled water for 90 s.20
Sections were examined and imaged with a Hitachi 7500
electron microscopy operated at 80 kV. Quantification was
achieved using about 10 sections per mouse hippocampus
and three mice were used for each treatment set.
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Results
The post synaptic density (PSD) protein of 95 KDa, PSD95—
a postsynaptic membrane-associated protein with a guany-
late kinase-like domain without any kinase activity—is an
established postsynaptic marker of spine and synapse
maturation.21–24 In neuronal signaling, it is reported to
exert a major influence on synaptic strength and plasticity
by recruiting AMPA receptors to the postsynaptic mem-
brane.22,23 On the basis of this information, we used
PSD95 expression and electron microscopy to demonstrate
5-HT1A-R-mediated synaptogenesis in the P15 hippocampus
and also elucidate the signaling cascade involved in this
process.
Stimulation of the 5-HT1A-R in organotypic cultures of
P15 hippocampal slices augments PSD95 expression,
spine formation and synaptogenesis. A dramatic 5-HT1A-
R-evoked increase in PSD95 expression was evident from
immunohistochemistry (Figure 1a) and it was inhibited in
presence of WAY100635 and the pharmacological inhibitors
of MEK (U0126, 10 mM) and PKC (bisindolylmaleimide I or
GFX, 2mM), respectively (Figures 1a–d). PSD95 was shown
as punctuate staining in the spines. The number of puncta
per unit length of the dendritic spines and puncta intensity
representing the number of PSD95 molecules per spine
showed a striking increase in presence of the 5-HT1A-R
agonist 8-OH-DPAT (DPAT). This DPAT-evoked increase in
spine formation was eliminated in presence of WAY, U0126
and GFX, thereby confirming the involvement of MEK-
Erk1/2 signaling and PKC in the 5-HT1A-R-mediated
induction of PSD95.
We also monitored the influence of 5-HT1A-R signaling on
synaptogenesis in organotypic cultures of hippocampal slices
by electron microscopy. The cultured P15 hippocampal slices
at 6DIV were treated with the 5-HT1A-R agonist 8-OH-DPAT
(DPAT) or carrier to show that the DPAT-treated slices
harbored a significantly higher number of excitatory synapses
(Po0.0001), which were marked by the presence of post-
synaptic densities (Supplementary Figures 1a and b).
Simultaneously, we used western blotting to monitor the
influence of 5-HT1A-R signaling on PSD-95 expression in
cultured hippocampal slices from P15 mice. We observed a
significant increase in PSD95 expression in the presence of
DPAT (100 nM). The PSD95 levels reached a peak after 16 h
of DPAT treatment (unpublished data) and the induction was
abrogated in the presence of the 5-HT1A-R antagonist
WAY100635 (WAY) (4mM), thus confirming the involvement
of the 5-HT1A-R in the induction of PSD95 (Supplementary
Figure 1c).
Intra-hippocampal infusion of DPAT and inhibitors into
P15 mice elicit PSD95 induction in vivo through the
5-HT1A-R, Erk1/2, PKCa pathway. Our earlier studies in the
hippocampal HN2-5 cells and cultured hippocampal slices
indicated that a 5-HT1A-R--ERK-PKCa pathway has an
important role in neuroprotection as well as increased
synaptic activity.12,25 In order to confirm that the same
5-HT1A-R--ERK-PKCa pathway also functions in vivo,
we performed intra-hippocampal injections26 of DPAT with
or without the pharmacological inhibitors into the right
hippocampus of P15 C57BL6 muse pups (Figures 2c
and d). After 24 h, the pups were subjected to intracardiac
perfusion of paraformaldehyde followed by isolation of the
ipsilateral (right) and contralateral hippocampi for sectioning
into 30-mM slices. The sections were processed for immuno-
histochemistry. The red staining for PSD95 was markedly
higher in the ipsilateral hippocampus from the DPAT-injected
brains than in the contralateral hippocampus or the hippo-
campi from carrier-treated brains (Figure 2d). Zooming in on
a CA1 region (indicated by the square area), we found that
this increase in the PSD95 staining was absent or sharply
diminished in slices that received WAY100635, U0126 or Ro
31-8220 (a selective PKCa inhibitor p10 nM; IC50¼ 5 nM)
in addition to DPAT18 (Figures 2a and b). This strongly
indicates that the same 5-HT1A-R mediated signaling path-
way as shown above in Figure 2 also boosts the expression
of PSD95 in vivo.
It should be noted that a P15 hippocampal slice cultured
6 days in vitro (6DIV) maintains its overall structure but
spreads out significantly on the substratum (membrane). This
allows the individual PSD95-immunopositive dendrites and
spines to be imaged clearly (Figure 1). In contrast, the
cryosections of the freshly isolated hippocampi from in vivo-
treated brains harbor densely packed dendrites, thus yielding
strong PSD95 immunostaining in the entire hippocampus
(Figure 2). High-magnification images acquired at  100
show the presence of punctate PSD95 immunostaining on the
dendrites and spines especially following 8-OH-DPAT treat-
ment (Figures 2e–g).
Two-dimensional cultures of hippocampal neurons form
synaptic connections in the horizontal plane, which allows for
double staining of pre- and postsynaptic terminals for specific
markers such as synaptophysin (pre-synaptic) and PSD95
(postsynaptic) and confocal imaging of both in the same
plane. In sharp contrast, hippocampal tissue in the 6DIV
cultures as well as the cryosections from in vivo treatment
were three-dimensional units, in which simultaneous imaging
of pre- and postsynaptic terminals was difficult to achieve by
confocal microscopy. Therefore, in addition to demonstrating
the induction of the postsynaptic protein PSD95, we have
performed electron microscopy to image and quantify the
hippocampal synapses.
Increased synaptogenesis via PKCa downstream of
5-HT1A-R in C57BL6 mouse hippocampus. In order to
determine the role of 5-HT1A-R mediated pathway in
synaptogenesis in vivo we performed electron microscopic
analysis on hippocampi obtained from brains that were infused
intra-hippocampally with DPAT (final intrahippocampal
concentration of 100 nM) in the absence or presence of
different pharmacological inhibitors. We observed that DPAT
treatment caused a significant increase in the number of
excitatory synapses in the hippocampal CA1 region. This
increase in synaptogenesis was abolished in presence of any
of the inhibitors: U0126, Ro 31-822018 and WAY. These
results confirm that 5-HT1A-R-mediated signaling via Erk and
PKCa causes induced synaptogenesis in vivo in P15 mouse
hippocampus (Figure 3).
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Intrahippocampal infusion of fluoxetine causes 5-HT1A-
R-, Erk1/2-, and PKCa-dependent induction of PSD95.
The optimum concentration of 5-HT1A agonist 8-OH-DPAT
(100 nM) for the activation of Erk1/2 had been determined
earlier from in vitro experiments using organotypic cultures
of P15 hippocampal slices.12 Although the same intra-
hippocampal concentration of 8-OH-DPAT allowed us to
confirm that a 5-HT1A-R-mediated signaling through Erk1/2
and PKCa causes PSD95 induction and synaptogenesis,
the physiological relevance of this phenomenon could be
elucidated only through an increase in intrasynaptic serotonin
concentration above the basal levels (o1 nM) in the P15
mouse hippocampus.15,27 This has been typically achieved
by administering fluoxetine (Prozac), which is an inhibitor of
the serotonin reuptake protein SERT. Albeit the same effect
from systemic infusion in adult mice,15,27 direct intracortical
infusion of a fluoxetine analog also causes a 3-5-fold
increase in extracellular serotonin within 60 min.28 We
investigated whether such augmented serotonin levels at
the hippocampal synapses would elicit the same 5-HT1A-R,
Erk and PKCa-mediated synaptogenic signaling in P15 mice.
As shown in Figures 4 and 5, intrahippocampal infusion of
fluoxetine into P15 mice caused a significant increase in
PSD95 expression and synaptogenesis and this effect was
eliminated upon inhibition of the Erk activator MEK with
U0126 and PKCa with Ro 31-8220.
The hierarchy of signaling molecules in the 5-HT1A-
R--Erk1/2-PKCa pathway in C57BL6 mouse
hippocampus. The widespread induction of PSD95 over
the entire hippocampus (Figure 3d) enabled us to perform
western-blot analysis on whole hippocampal lysates to study
the possible link among 5-HT1A-R, Erk and PKCa. We used
T638 phosphorylation of PKCa and dual phosphorylation
of T202 and Y204 on Erk1/2 as a measure of stimulation of
these kinases. As shown in Supplementary Figures 2a and b,
short-term stimulation of the hippocampal 5-HT1A-R by
intrahippocampal infusion of 8-OH-DPAT (final concen-
tration of 100 nM) in the absence and presence of inhibitors
followed by killing of the treated mice after 60 min, removal of
hippocampi, and lysis in protease inhibitor-containing buffers
yielded protein samples that could be analyzed by western
blotting for P-PKCa and P-Erk. We observed a significant
induction of P-PKCa in the DPAT-infused hippocampi, which
was eliminated in the presence of WAY, U0126 and Ro 31-
8220 (Supplementary Figure 2a). In contrast, 5-HT1A-R-
mediated induction of P-Erk was eliminated in the presence
of WAY and U0126 but not Ro 31-8220 (Supplementary
Figure 2b). These two data sets place Erk above PKCa
in a 5-HT1A-R signaling pathway the long-term effect of
which would be increased synaptogenesis (Supplementary
Figure 2c).
Downstream involvement of PKCa was utilized to induce
PSD95 and synaptogenesis in C57BL6 5-HT1A-R(/)
mice. To further confirm the role of 5-HT1A-R-mediated
signaling pathway in the expression of PSD95, we used
5-HT1A-R(/) C57BL6 mice at P15. These mice were
injected with carrier, DPAT and bryostatin. Bryostatin is a
well-known memory-enhancing drug, which selectively
activates PKC.18 We observed that PSD95 expression was
significantly higher (Po0.0001) in the bryostatin-treated
hippocampi than the carrier or DPAT-treated ones. This
enhancement was observed in the CA1 region of the hippo-
campus (Figures 6a and b) as well as CA3 and DG regions of
the hippocampus (data not shown here). Simultaneous
electron microscopy analysis revealed that the bryostatin-
treated hippocampi harbored significantly more CA1
excitatory synapses (Figures 6c–f).
In vivo analysis in SW mice at P15 show the involvement
of PKCa in the induction of PSD95. To address the
question whether this 5-HT1A-R- and PKCa-mediated
signaling was strain-independent, we performed parallel
experiment with wild-type SW mice with intact 5-HT1A-Rs.
Inhibition of the downstream effector PKCa with Ro 31-8220
again caused elimination of the 5-HT1A-R-mediated induction
of PSD95 (Supplementary Figures 3a and b). In order to
confirm the involvement of PKCa in the increased
hippocampal expression of PSD95 at P15 in this mouse
strain, we used SW 5-HT1A-R (/) mice and stimulated the
downstream molecule, PKCa, by injecting the suggested
dose of bryostatin18 intra-hippocampally. As expected,
DPAT treatment elicited no increase in PSD95 staining in
these 5-HT1A-R-deficient mice, but bryostatin-treatment
resulted in a significantly higher level of PSD95 expression
(Supplementary Figures 3c and d). This re-confirms that
the 5-HT1A-R-mediated signaling pathway leads to higher
expression of PSD95 in the hippocampus of P15 SW mice.
Absence of the 5-HT1A-R results in a decreased density
of excitatory synapses in the hippocampus of P15
mice. On the basis of our observation that 5-HT1A-R
signaling in the hippocampus was critical in synapto-
genesis, an obvious question remains, ‘Is the hippocampal
synaptic density significantly lower in the 5-HT1A-R(/)
mice?’ As shown in Supplementary Figures 4a, b, and c, the
5-HT1A-R(/) mice harbor a significantly lower number
of excitatory synapses in the CA1 region (Po0.0001). As
explained in the discussion, this could have a detrimental
effect on hippocampal maturation, which in turn could
account for the behavioral abnormalities observed by
others in these mice.4–7
Figure 1 Increased PSD95 in dendritic spines upon 5-HT1A-R activation in cultured hippocampal slices: involvement of Erk1/2 and PKC. Organotypic cultures of P15
hippocampal slices at 6DIV were treated with DPAT (100 nM) (abbreviated as D in the graphs) in the absence and presence of WAY100635 (4 mM) (WAY), U0126 (10 mM) (U),
or GFX (2 mM) for 16 h (Scale bar: 50mM). The slices were fixed and immunostained to detect PSD95 expression in dendritic spines. DPAT treatment caused a significant
increase in both PSD95 expression (puncta intensity, c, e, and g) as well as spine number per unit length (b, d, and f). This increase in PSD95 and spine density was
eliminated in the presence of WAY100635, U0126 and GFX (a-g). Quantification from three experiments each with triplicate slices revealed significance (b, d, and f:
*Po0.001 DPAT versus all other groups); (c, e, and g: *Po0.001 DPAT versus all other groups; n¼ 3).
5-HT1A receptor-linked synaptogenesis
A Mogha et al
5
Translational Psychiatry
N
eu
N
 
PS
D9
5 
M
er
ge
d 
WAY+DPAT
Ipsilateral
Ca
rr
ie
r
D
PA
T
Carrier
200
*
**
PS
D9
5 
Ex
pr
es
sio
n 
in
CA
1 
at
 P
15
 (%
 C
arr
ier
)
150
100
50
0
CA
RR
IE
R
D
PA
T 
(D
)
W
AY
W
AY
+D
U0
10
26
+D BA
Y
R
o
31
-8
22
0+
D
WAY + DDPAT
Contralateral
BAY3702 Carrier DPAT WAY Ro+DPAT U+DPAT 
Figure 2 A 5-HT1A-R-mediated signaling pathway involving Erk1/2 and PKCa causes heightened expression of PSD95 in P15 mouse hippocampus. (a) A DPAT (100 nM)-
evoked induction in PSD95 expression in 24 h is eliminated in the presence of WAY100635 (4 mM) (WAY), U0126 (10 mM) (U), and the selective PKCa inhibitor Ro 31-8220 at
10 nM (Ro). A second 5-HT1A-R agonist BAY3702 (100 nM) also causes induced PSD95 expression (Scale bar: 50 mM). (b) Densitometric quantification from three infusions
(three mice and quadruplicate sections from each mouse) shows a significant induction of PSD95 following infusion of DPAT or BAY3702 (BAY) (*Po0.001 DPAT versus all
other groups except BAY3702; **P¼ 0.1345 DPAT versus BAY3702) (n¼ 3). (c) The injection track and the site of injected drugs in the dorsal hippocampus marked by
Coommassie Blue. (d) The ipsilateral hippocampus shows DPAT-evoked induction of PSD95 (red), whereas the contralateral hippocampus does not. These images were
acquired at  4 magnification (Scale: 500mM). The square area in the CA1 region of the ipsilateral hippocampus was imaged at  40 and then used for the comparison of
histochemical staining presented in panel a. (e–g) High-magnification images acquired at  100 show strong, punctate, PSD95 immunoreactivity in numerous dendrites and
spines in the CA1 region of a DPAT-infused hippocampus.
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The induced synaptogenesis was persistent even 5 days
after infusion of 8-OH-DPAT or Fluoxetine. A pertinent
argument is that the observed increase in synaptogenesis
could be only transient and therefore of insignificant
consequence. To address this important point, we per-
formed electron microscopy 5 days after carrier, 8-OH-DPAT
or fluoxetine treatment. As shown in Supplementary Figure 5,
the boosted density of excitatory synapses observed in
the CA1 region after 24 h persisted even 5 days after DPAT
or Flx treatment at P15. Intriguingly, systemic infusion
(intraperitoneal) of fluoxetine from P15, both once as well
as chronic (daily) for 5 days, caused an inhibition of the
number of CA1 synapses compared with the carrier-infused
controls (Supplementary Figure 6).
Discussion
Mice open their eyes between P12 and P14 and closely
thereafter (P15) is a stage of heightened synaptogenesis.29
Our report shows that 5-HT1A-R signaling has a crucial
role at this stage by triggering PSD95 expression and
formation of excitatory synapses in the hippocampus at
P15.30 A deficiency in 5-HT1A-R expression is associated
with a significant decrease in these synapses (Supplementary
Figure 4) and the 5-HT1A-R-linked increase in excitatory
synapses in the wild-type hippocampal CA1 region persists for
at least 5 days (Supplementary Figure 5). By elucidating a
5-HT1A signaling pathway linked to synaptogenesis, we also
submit a possible strategy of combating 5-HT1A-R deficiency
via downstream stimulation of PKCa with the memory-
enhancing drug bryostatin (Figure 6 and Supplementary
Figure 3).18 The same 5-HT1A-R-mediated PSD95 induction
and synaptogenesis is observed in the presence of prozac
(Flx) (Figures 4 and 5), which causes an increase in
extracellular serotonin. This raises the possibility that a local
increase in serotonin during inappropriate stages may result in
unwanted overconnectivity in cortical centers. By applying
intra-hippocampal infusion of drugs, we have avoided all
confounds ensuing from systemic application of agonists or
Flx, which could cause differential activation of somato-
dendritic and hetero 5-HT1A-R molecules. Furthermore, our
experiments involved infusion of pharmacological agents
into the right hippocampus, which left the contralateral
hippocampus essentially unaffected, thereby confirming that
the 5-HT1A-R agonists produce a specific effect in the
ipsilateral hippocampus (Figure 2d).
Confirming our concern about confounds ensuing from
systeming administration of Flx, intraperitoneal infusion of Flx
into P15 mice caused an inhibition in the number of CA1
synapses compared with that observed in carrier-infused mice
(Supplementary Figure 6). It should be noted that the raphe´
neurons, which actually synthesize 5-HT and express 5-HT1A
receptors and SERT, develop much earlier than the hippo-
campal neurons. Therefore, it is quite likely that peripherally
administered fluoxetine first reaches brain-stem raphe´ neu-
rons, blocks the local SERT molecules, causing a local
increase in extracellular 5-HT, which in turn binds to the ample
somatodendritic 5-HT1A receptors to cause an inhibition of
5-HT firing at the hippocampal terminals. In contrast, when
systemic fluoxetine molecules eventually diffuse to the
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Figure 3 The 5-HT1A-R, Erk, PKCa signaling cascade induces synaptogenesis in the P15 hippocampus. (a) Electron microscopy revealed a significant increase in
synapse number in the hippocampal CA1 region of the DPAT-infused mice. This DPAT-stimulation of synaptogenesis was eliminated in the presence of WAY100635 (4 mM),
U0126 (10mM) and Ro 31-8820 (Ro) (Scale bar: 500 nm; post-synaptic terminals highlighted in yellow). (b) Quantification from three mice with eight sections per mouse
revealed a significant effect of 5-HT1A-R signaling, which was eliminated in the presence of U0126 and Ro 31-8820 (*Po0.001 for DPAT versus all other groups; n¼ 3).
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relatively less-developed hippocampal region, their effect on
the still-developing synapses with the maturing postsynaptic
hippocampal neurons is likely to be far less than that in the
raphe´ region. This out-of-balance high Flx-evoked 5-HT
activity in the raphe´ region is expected to cause a decrease
in net 5-HT firing at the hippocampal synapses, which could
explain the apparent decrease in the number of CA1
synapses after systemic Flx treatment of P15 mice (Supple-
mentary Figure 6). This should not be compared with
the effect of systemic administration of Flx in adult animals
wherein both the raphe´ as well as the hippocampal regions
are fully developed with the full repertoire of SERT molecules
and 5-HT receptors.
The effects of the inhibitors of the Erk pathway (U0126) and
PKCa (Ro 31-8220) on 5-HT1A-R-linked PSD95 induction and
synaptogenesis were mutually occlusive, which indicated that
these two signaling molecules functioned in the same path-
way. Short-term DPAT treatment (60 min) followed by western
blotting revealed that the activation of PKCa was sensitive to
U0126, which placed PKCa downstream of Erk (Supplemen-
tary Figures 2b and c). This inference was consistent with our
earlier observation that in hippocampal neuron-derived HN2
cells, Erk physically bound to and phosphorylated PKCa at
T638, which was crucial for the activation of PKCa.31 Earlier
studies have also shown that 5-HT1A-R-mediated activation
of PLC occurs in a hippocampal neuron-derived cell line
HN2-525,32 and many other neuronal cell lines through
Gig.33,34 This pathway could be responsible for IP3-mediated
calcium release from the endoplasmic reticulum, thereby
causing stimulation of the Ras-Raf-1-MEK-Erk1/2 path-
way via Ca2þ -sensitive signaling proteins like Pyk2 and
Src.35–38
The 5-HT1A-R agonist 8-OH-DPAT also stimulates the
adenylyl cyclase-coupled 5-HT7 receptor causing an increase
in intracellular cAMP levels. This would cause stimulation of
protein kinase A, which is known to stimulate the Ras homolog
Rap-1 through phosphorylation. Stimulated Rap-1 binds to
and activates B-Raf that phosphorylates MEK to stimulate the
Erk pathway.39 The concentration of the 5-HT7-R in the adult
cortex is much lower than that of the 5-HT1A-R. Nonetheless,
Figure 4 Infusion of fluoxetine into P15 mouse hippocampus causes induction of PSD95 via 5-HT1A-R, Erk1/2, and PKCa. (a) Intrahippocampal infusion of fluoxetine (Flx)
caused a significant increase in PSD95 expression in all regions of the hippocampus, but confocal images from CA1 are shown (Scale bar: 50 mM). (b–d) Quantification from
three mice performed with quadruplicate sections per mouse showed a significant increase in PSD95 expression in the presence of Flx, which was eliminated in the presence
of WAY100635, U0126 and Ro 31-8820 (Po0.0001 for Flx versus all other groups for each hippocampal region; n¼ 3).
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based on 5-HT7-R-mediated membrane depolarization, the
cortical expression of the two receptors at P15 appears to be
comparable.40 Although 8-OH-DPAT binds much more avidly
to 5-HT1A-R (KDB1 nM) than to 5-HT7-R (KD¼ 50 nM),41,42 the
relative abundance of the two 8-OH-DPAT-binding receptors
at P15 evokes the prospect that in the 5-HT1A-R (/) mice at
P15, 8-OH-DPAT may cause 5-HT7-R-mediated activation
of Erk, thereby stimulating PKCa, which would then elicit
induced expression of PSD95. Contrary to this possibility,
we observed no 8-OH-DPAT-evoked increase in PSD95
expression in 5-HT1A-R(/) mice of either C57BL6 or SW
background. Although volume-renderings of some z-stack
images showed a slight increase (Supplementary Figure 3;
SW 5-HT1A-R/) or a slight decrease (Figure 6) in PSD95
immunostaining in the 8-OH-DPAT-treated hippocampi, these
changes were not significant among the three sets of mice and
large number hippocampal slices used for statistical analysis.
In sharp contrast, in both strains of mice, bryostatin caused a
dramatic and significant increase in PSD95 expression in the
CA1 region. Thus, 5-HT7-R-mediated signaling is unlikely
to have any significant effect on PSD95 expression in the
P15 hippocampus.
Prior studies indicate that multiple subunits of the GABAA
receptor are phosphorylated by Ca2þ -dependent conven-
tional PKCs,43–46 thereby causing inhibition of GABAA
signaling and internalization of the receptor.47 Thus, the
activation of PKCa (a conventional Ca2þ -dependent PKC) via
5-HT1A-R-mediated signaling is expected to cause an inhibi-
tion of GABAA receptor function in the target pyramidal CA1
neurons of the SC pathway. Such reduction of inhibitory
signals would lead to an increase in the net excitatory signals
in the pyramidal neurons of the CA1 area (fEPSP), which
could cause increased synaptic strength, induction in PSD95,
and augmented synaptogenesis as observed in the hippo-
campus after 24-h of in vivo 8-OH-DPAT treatment.
Alternative Erk and PKC-dependent mechanisms could
also operate beyond the acute phase of fEPSP (1 h), causing
an induction in PSD95. Prior studies by Elkobi et al. have
demonstrated Erk-dependent PSD95 induction in the gusta-
tory cortex as an essential step in taste learning;48 however,
the mechanistic link between Erk activity and PSD95
induction has not been elucidated. Our results strongly
indicate that Erk-dependent induction of PSD95 in the
hippocampus involves PKCa. Among molecules that may
link PKC to the induction of PSD95, neuroligin-1 (Nrg), which
elicits induced expression of PSD95,49 is a likely candidate.
The intracellular domain of Nrg is shed in a PKC-dependent
manner,50 following which the released Nrg fragment com-
plexes with the transcription factor Eos to bind to an enhancer
element in the PSD95 promoter to elicit induced expression of
PSD95.49 Further investigation will test this possibility.
Performed in mice of 129S6/SvEvTac;C57BL/6;CBA mixed
background, pharmacological inhibition of 5-HT1A-R from
P13-34 has been shown to phenocopy the effect of neonatal
absence of this receptor, thereby linking 5-HT1A-R-mediated
CaMIIa stimulation to the maintenance of normal anxiety
levels in adulthood.51 Our analyses, performed in mice of
different backgrounds (C57BL6 and SW), submit Erk1/2 and
PKCa as possible substrates for affective disorders, linked
to aberrant 5-HT1A-R expression/signaling. Intriguingly, in
dissociated cell cultures, Ferreira et al. report the opposite
finding that 5-HT1A-R signaling causes suppression of growth
Figure 5 Intra-hippocampal infusion of fluoxetine into P15 hippocampus causes induction of synaptogenesis through 5-HT1A-R, Erk1/2 and PKCa. (a) A significant
increase in synapses was observed in the CA1 region of the Flx-infused hippocampi. (b) Quantification from three mice performed with eight sections per mouse revealed a
significant increase the number of synapses in the presence of Flx, which was eliminated in the presence of WAY, U0126 and Ro 31-8820 (Po0.0001 for Flx versus all other
groups; n¼ 3).
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and sprouting of oblique dendrites.52 However, at 3–5
postnatal weeks, the mice used in these studies were older
than the P15 mice used here. More consistent with our
observation, Chen et al. have demonstrated 5-HT1A-R-
mediated mobilization of mitochondria,53 which may stimulate
synaptogenesis.54 However, the specific stage of P15 has not
been the focus of these studies, which may contribute to the
mechanistic difference (involving Akt-GSK3b) observed by
Chen et al.53
In mouse and rat pups, the event of eye opening at P12-14
is marked by a dramatic increase in PSD95 expression and
redistribution into synapases.29 Thus, as mentioned in the
introduction, P15 is at the epicenter of a major synaptogenic
event,13 and a significant part of it is visual activity-driven. By
elucidating 5-HT1A-R, Erk, and PKCa-mediated PSD95
induction and synaptogenesis and also demonstrating that
the absence of the 5-HT1A-R in the 5-HT1A-R (/) mice is
associated with a decrease in synapse density in the CA1
region at P15, we have strengthened the possibility that the
hippocampal 5-HT1A-R has the essential role of orchestrating
synaptogenesis. Our study also suggests that sluggish
hippocampal development because of impaired 5-HT1A-R,
Erk, PKCa signaling could be remedied by the use of the PKC-
activating drug bryostatin.
Our experiments have used ketamine for anesthesia and a
recent study has demonstrated ketamine regulates hippo-
campal synapse formation.55 As both control and 5-HT1A
agonist-treated mice used in our experiments were anesthe-
tized using the same concentration of ketamine, it is unlikely
that a different anesthetic would alter our conclusion. How-
ever, it will be important to analyze how anesthetics regulate
synaptogenesis at P15.
Normal brain development requires that early postnatal
synaptogenesis be followed by a phase of synaptic pruning for
the refinement of neuronal connections. Based on our results
from inra-hippocampal infusion of Flx, we initially conjectured
that the use of prozac during the period of synaptic pruning
could impair brain development by triggering unwanted
synaptogenesis through the same 5-HT1A-R pathway. Intrigu-
ingly, systemic administration of Flx in P15 mice actually
caused a significant decrease in the number of excitatory
synapses in the CA1 region (Supplementary Figure 6).
Therefore, administration of prozac may impair neonatal brain
development by inhibiting synaptogenesis.
Our strategy of increasing local extracellular 5-HT by
intrahippocampal administration of Flx may replicate the state
of increased cortical serotonin, which has been reported in
juvenile autistic subjects.2 The resulting synaptogenesis
Figure 6 Bryostatin treatment of P15 5-HT1A-R (/) C57BL6 mice leads to heightened expression of PSD95 and boosted synaptogenesis. (a) In the 5-HT1A-R-deficient
mice, PSD95 staining is increased in the CA1 region in bryostatin-, but not DPAT-infused mice (Scale bar 50 mM). (b) Quantification of volume-rendered images from three
experiments with triplicate sections per treatment revealed a significant increase in PSD95 in the presence of bryostatin (Po0.0001 bryostatin versus all other groups; n¼ 3).
(c–f) Electron microscopy revealed a simultaneous increase in the number of synapses in the bryostatin-treated animals (Scale bar: 500 nm) (f, Po0.0001 bryostatin versus
all other groups; n¼ 3).
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through 5-HT1A-R signaling may precipitate short-range
hyper-connectivity (for example, within the hippocampus),
which is an endophenotype of autism.14
The half-life of DPAT in the body and the brain has been
reported as 143 min and 26 min, respectively.56,57 Therefore,
the long-term synaptogenic effect observed after 5 days is
likely to be initiated through an DPAT or 5-HT-evoked change
in gene expression. This suggests the existence of a direct
relationship between the basal profiles of 5-HT1A-R expres-
sion and signaling and synapse formation during early
postnatal hippocampal development. Our observation of a
lower level of excitatory synaptic connections in the hippo-
campal CA1 region in the 5-HT1A-R(/) mice strongly
supports this postulate (Supplementary Figure 4). In conclu-
sion, our findings elucidate a 5-HT1A-R-linked synaptogenic
pathway involving Erk1/2 and PKCa in P15 mouse hippo-
campus, which may have a pivotal role in early postnatal brain
development.
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